Sarah Abu Kar

508 total citations
8 papers, 367 citations indexed

About

Sarah Abu Kar is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Sarah Abu Kar has authored 8 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Sarah Abu Kar's work include Acute Myeloid Leukemia Research (2 papers), RNA Research and Splicing (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Sarah Abu Kar is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), RNA Research and Splicing (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Sarah Abu Kar collaborates with scholars based in United States, Australia and China. Sarah Abu Kar's co-authors include Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Kathryn M Guinta, Andrés Jerez, Manuel Afable, Ramón V. Tiu, Bartlomiej Przychodzen, Hirotoshi Sakaguchi, Richard A. Padgett and Valeria Visconte and has published in prestigious journals such as Nature Communications, Blood and Journal of the American Society of Nephrology.

In The Last Decade

Sarah Abu Kar

7 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Abu Kar United States 3 241 230 132 38 36 8 367
Sofia Kade Germany 2 256 1.1× 188 0.8× 125 0.9× 27 0.7× 18 0.5× 3 321
Manoj Bupathi United States 2 194 0.8× 190 0.8× 103 0.8× 24 0.6× 23 0.6× 2 282
Patrick Löffeld Germany 2 255 1.1× 189 0.8× 123 0.9× 27 0.7× 17 0.5× 3 325
B Przychodzen United States 8 280 1.2× 234 1.0× 158 1.2× 58 1.5× 29 0.8× 9 409
Margot Morabito France 6 263 1.1× 119 0.5× 170 1.3× 21 0.6× 59 1.6× 11 335
Heather Cazzolli United States 5 270 1.1× 157 0.7× 204 1.5× 50 1.3× 41 1.1× 8 369
Edy Hasrouni United States 5 264 1.1× 225 1.0× 108 0.8× 20 0.5× 13 0.4× 17 374
M Berends Netherlands 3 329 1.4× 416 1.8× 161 1.2× 42 1.1× 33 0.9× 4 578
Fiona Watkins United Kingdom 6 246 1.0× 180 0.8× 117 0.9× 38 1.0× 28 0.8× 8 379
Susanna Akiki Qatar 9 219 0.9× 167 0.7× 141 1.1× 38 1.0× 22 0.6× 32 347

Countries citing papers authored by Sarah Abu Kar

Since Specialization
Citations

This map shows the geographic impact of Sarah Abu Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Abu Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Abu Kar more than expected).

Fields of papers citing papers by Sarah Abu Kar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Abu Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Abu Kar. The network helps show where Sarah Abu Kar may publish in the future.

Co-authorship network of co-authors of Sarah Abu Kar

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Abu Kar. A scholar is included among the top collaborators of Sarah Abu Kar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Abu Kar. Sarah Abu Kar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pan, Yu, Shirong Cao, Yinqiu Wang, et al.. (2025). Myeloid EGFR deficiency accelerates recovery from AKI via macrophage efferocytosis and neutrophil apoptosis. Nature Communications. 16(1). 4563–4563. 1 indexed citations
2.
Kar, Sarah Abu & Raymond C. Harris. (2025). Chronic kidney disease and sex dimorphism. Current Opinion in Nephrology & Hypertension. 34(4). 314–321. 1 indexed citations
3.
Kar, Sarah Abu, et al.. (2023). Infection: A Potential Trigger of Recurrent C3 Glomerulonephritis in a Kidney Transplant Recipient. Journal of the American Society of Nephrology. 34(11S). 609–609.
4.
Cao, Shirong, Yu Pan, Andrew S. Terker, et al.. (2023). Epidermal growth factor receptor activation is essential for kidney fibrosis development. Nature Communications. 14(1). 7357–7357. 23 indexed citations
5.
Kar, Sarah Abu & Amandeep Kaur. (2022). Evans Syndrome in the Context of Incomplete Systemic Lupus Erythematosus. Cureus. 14(6). e25795–e25795. 1 indexed citations
6.
Kar, Sarah Abu, et al.. (2022). Early Utilization of Intravenous Immunoglobulin in Heparin-Induced Thrombocytopenia for Limb Salvaging Purposes. Cureus. 14(3). e23202–e23202. 1 indexed citations
7.
Kar, Sarah Abu, Ania Jankowska, Hirokazu Makishima, et al.. (2012). Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica. 98(1). 107–113. 61 indexed citations
8.
Makishima, Hideki, Valeria Visconte, Hirotoshi Sakaguchi, et al.. (2012). Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood. 119(14). 3203–3210. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026